NIH-funded research R01 grant

Using nitric oxide-releasing compounds to improve healing of complex wounds

Official title: Nitric oxide-releasing glycosaminoglycans for treating complex wounds

Funded at Univ of North Carolina Chapel Hill · NIH-11002015 · Data updated 2026-11-12

This study is looking at new ways to help heal stubborn wounds, especially for people with diabetes, by using special materials that can release a helpful molecule to fight infections and support healing.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2026
Funding year2025
Award (this year)$343,284
NIH project number5R01DK132778-03
Project IDNIH-11002015 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with chronic wounds, particularly those affected by diabetes or other conditions that impair healing.

Less likely to help

Patients with acute wounds or those not suffering from chronic conditions may not benefit from this research.

What this research studies

This research focuses on developing new treatments for chronic wounds that are slow to heal due to infections and inflammation, particularly in patients with conditions like diabetes. The approach involves creating glycosaminoglycan biopolymers that can release nitric oxide, a molecule that helps fight bacteria and modulate the immune response. By addressing both the infection and the underlying immune issues, this therapy aims to enhance the healing process for patients with complex wounds. The research will involve laboratory testing and potentially clinical trials to evaluate the effectiveness of these new compounds.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for chronic wounds, reducing the risk of complications such as amputations.

How similar studies have gone: Previous research has shown promise in using nitric oxide for wound healing, suggesting that this approach could be a significant advancement in treatment.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Schoenfisch, Mark H — Univ of North Carolina Chapel Hill
  • Study coordinator: Schoenfisch, Mark H

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.